New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment
Por um escritor misterioso
Descrição
In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).
IJERPH, Free Full-Text
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
COVID-19: Drug Targets and Potential Treatments
The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC initiative: Molecular Therapy - Nucleic Acids
NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies
Frontiers Psychophysical therapy and underlying neuroendocrine mechanisms for the rehabilitation of long COVID-19
NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
Frontiers Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial - eClinicalMedicine
Study identifies risk factors for long-haul COVID disease in adults - Mayo Clinic News Network
Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
COVID-19 - Wikipedia
de
por adulto (o preço varia de acordo com o tamanho do grupo)